Clinical Trial Update: Trial of S-1 Plus Cisplatin in Gastric Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating S-1 plus cisplatin for gastric cancer; current status is unknown. Sponsor: Sun Yat-sen University.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Gastric Cancer | Phase 3 | Status: UNKNOWN